This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, H.
Right arrow Articles by Liu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, H.
Right arrow Articles by Liu, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2006, p. 250-255, Vol. 50, No. 1
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.1.250-255.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

AsnB Is Involved in Natural Resistance of Mycobacterium smegmatis to Multiple Drugs

Huiping Ren and Jun Liu*

Department of Medical Genetics and Microbiology, University of Toronto, Medical Sciences Building, Room 4382, One King's College Circle, Toronto, Ontario M5S 1A8, Canada

Received 5 August 2005/ Returned for modification 29 September 2005/ Accepted 12 October 2005

Mycobacteria are naturally resistant to most common antibiotics and chemotherapeutic agents. The underlying molecular mechanisms are not fully understood. In this paper, we describe a hypersensitive mutant of Mycobacterium smegmatis, MS 2-39, which was isolated by screening for transposon insertion mutants of M. smegmatis mc2155 that exhibit increased sensitivity to rifampin, erythromycin, or novobiocin. The mutant MS 2-39 exhibited increased sensitivity to all three of the above mentioned antibiotics as well as fusidic acid, but its sensitivity to other antibiotics, including isoniazid, ethambutol, streptomycin, chloramphenicol, norfloxacin, tetracycline, and ß-lactams, remained unchanged. Uptake experiment with hydrophobic agents and cell wall lipid analysis suggest that the mutant cell wall is normal. The transposon insertion was localized within the asnB gene, which is predicted to encode a glutamine-dependent asparagine synthetase. Transformation of the mutant with wild-type asnB of mc2155 or asnB of Mycobacterium tuberculosis complemented the drug sensitivity phenotype. These results suggest that AsnB plays a role in the natural resistance of mycobacteria.

* Corresponding author. Mailing address: 4382 Medical Sciences Building, Department of Medical Genetics and Microbiology, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. Phone: (416) 946-5067. Fax: (416) 978-6885. E-mail: jun.liu{at}utoronto.ca.

Antimicrobial Agents and Chemotherapy, January 2006, p. 250-255, Vol. 50, No. 1
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.1.250-255.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»